Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Vascular Remodeling and the Effects of Angiogenic Inhibition in Diabetic Retinopathy

This study has been completed.
Sponsor:
Information provided by:
National Eye Institute (NEI)
ClinicalTrials.gov Identifier:
NCT00411333
First received: December 13, 2006
Last updated: November 9, 2010
Last verified: November 2010